Waist circumference stronger risk marker than BMI for obesity-related cancer in men, but not women
Peer-Reviewed Publication
Updates every hour. Last Updated: 12-Jul-2025 14:10 ET (12-Jul-2025 18:10 GMT/UTC)
Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) and published in The Journal of the National Cancer Institute shows that waist circumference (WC) is a stronger risk marker than BMI for developing obesity-related cancers in men, but not women. The study was conducted by Dr. Ming Sun, Dr. Josef Fritz and Dr. Tanja Stocks, Lund University, Malmö, Sweden, and colleagues.
Treatment of B-cell Acute Lymphoblastic Leukaemia has been greatly improved by CAR-T therapies, but relapse is still very common. An international team has now found in animal models a new approach that offers “a promising therapeutic strategy”.
The results are published in ‘Blood’ by researchers from the Josep Carreras Leukaemia Research Institute and the Hospital Universitario 12 de Octubre – Spanish National Cancer Research Center (CNIO), among other institutions.
“Although in the preclinical stage, this research is a first step toward improving treatments for B-ALL patients”, authors say. “The goal is to enhance the effectiveness of CAR-T therapy and reduce relapses”.
A t-shirt that monitors a patient’s vitals after urological surgery for cancer could help people return from hospital sooner to recover at home. The device, worn for around two weeks under clothes for three-hour windows each day, enabled patients to feel safer and more reassured than a control group in a pilot study of 70 individuals.
Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group.